Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review

General Hospital Psychiatry

Volumn 30, Issue 5, 2008, Pages 471-475

  Arbaizar, Beatriz ^a   Gómez Acebo, Inés ^b,c   Llorca, Javier ^b,c  

^a HOSPITAL DE LAREDO   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Binge eating disorder; Bulimia nervosa; Controlled clinical trial; Topiramate

Indexed keywords

PLACEBO; TOPIRAMATE;

AMENORRHEA; ARTICLE; ATTENTION DISTURBANCE; BINGE EATING DISORDER; BULIMIA; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; FLU LIKE SYNDROME; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPESTHESIA; LANGUAGE DISABILITY; LEG CRAMP; MEMORY DISORDER; NAUSEA; NERVOUSNESS; OBESITY; PARESTHESIA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; TASTE DISORDER; TESTICULAR SORENESS; TESTIS DISEASE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; XEROSTOMIA;

ADOLESCENT; ADULT; ANTICONVULSANTS; BULIMIA NERVOSA; CONTROLLED CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 50949106351     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2008.02.002     Document Type: Article

References (27)

1. van Passel L., Arif H., and Hirsch L.J. Topiramate for the treatment of epilepsy and other nervous system disorders. Expert Rev Neurotherapeutics 6 (2006) 19-31
2. Johnson B.A., Ait-Daoud N., Akhtar F.Z., et al. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61 (2004) 905-912
3. Johnson B.A., Rosenthal N., Capèce J.A., et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298 (2007) 1641-1651
4. Johannessen Landmark C. Targets for antiepileptic drugs in the synapse. Med Sci Monit 13 (2007) 1-7
5. Rogawski M.A., and Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10 (2004) 685-692
6. Johannessen Landmark C. Relations between mechanisms of action and clinical efficacy of antiepileptic drugs in non-epilepsy conditions. CNS Drugs 22 (2008) 27-47
7. Bray G.A., Hollander P., Klein S., et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 1 (2003) 722-733
8. Wilding J., Van Gaal L., Rissanen A., Vercruysse F., and Fitchet M. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 28 (2004) 1399-1410
9. Hettes S.R., Gonaga J., Heyming T.W., et al. Dual roles in feeding for AMPA/kainite receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior. Brain Res 992 (2003) 167-178
10. Nickel C., Tritt K., Muehlbacher M., et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord 38 (2005) 295-300
11. Carter W.P., Hudson J.I., Lalonde J.K., et al. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 34 suppl (2003) S74-S88
12. Grilo C.M., Masheb R.M., and Salant S.L. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial. Biol Psychiatry 57 (2005) 1193-1201
13. McElroy S.L., Arnold L.M., Shapira N.A., et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160 (2003) 255-261
14. Milano W., Petrella C., Casella A., et al. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenalin, in the treatment of binge eating disorder: a placebo-controlled study. Adv Ther 22 (2005) 25-31
15. Appolinario J.C., Bacaltchuk J., Sichieri R., et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 60 (2003) 1109-1116
16. Wilfley D.E., Crow S.J., Hudson J.I., et al. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry 165 (2008) 51-58
17. McElroy S.L., Kotwal R., Guerdjikova A., et al. Zonisamide in the treatment of binge eating disorder with obesity: a placebo-controlled trial. J Clin Psychiatry 67 (2006) 1897-1906
18. McElroy S.L., Guerdjikova A., Kotwal R., et al. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. J Clin Psychiatry 68 (2007) 390-398
19. McElroy S.L., Hudson J.I., Capece J.A., et al. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61 (2007) 1039-1048
20. Claudino A.M., Oliveira I.R., Appolinario J.C., et al. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder. J Clin Psychiatry 68 (2007) 1324-1332
21. Hoopes S.P., Reimherr F.W., Hedges D.W., et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial: Part 1. Improvement in binge and purge measures. J Clin Psychiatry 64 (2003) 1335-1341
22. Stanley B.G., Ha L.H., Spears L.C., et al. II. Lateral hypothalamic injections of glutamate, kainic acid, d,l-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic or N-methyl-d-aspartic acid rapidly elicit intense transient eating in rats. Brain Res 613 (1993) 88-95
23. Hettes S.R., Heyming T.W., and Stanley B.G. Stimulation of lateral hypothalamic kainate receptors selectively elicits feeding behavior. Brain Res 1184 (2007) 178-185
24. Shapira N.A., Goldsmith T.D., and McElroy S.L. Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 61 (2000) 368-372
25. Appolinario J.C., Fontenelle L.F., Papelbaum M., Bueno J.R., and Coutinho W. Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatry 47 (2002) 271-273
26. McElroy S.L., Shapira N.A., Arnold L.M., et al. Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 65 (2004) 1463-1469
27. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194